Skip to content

Insider · CIK 0002090481

Matthew Eugene Worley

director

Files at CCLFX (Cliffwater Corporate Lending Fund), CELFX (Cliffwater Enhanced Lending Fund), CPEFX (Cascade Private Capital Fund). First filing Mar 20, 2026, latest Apr 2, 2026.

Matthew Eugene Worley files SEC Form 4 as director at CCLFX (Cliffwater Corporate Lending Fund), and also at CELFX (Cliffwater Enhanced Lending Fund), CPEFX (Cascade Private Capital Fund). Since Mar 20, 2026, Matthew Eugene Worley has reported 3 open-market buys worth $1.4M and 0 open-market sells worth $0, the latest filed on Apr 2, 2026.

A track record needs three past buys with six months of prices behind them; Matthew Eugene Worley has 0, so none is measured yet.

The newest scored trade: bought $300k of CCLFX on Apr 1, 2026, filed Apr 2, 2026, scored 47 (moderate). In the last 12 months: 3 buys worth $1.4M and 0 sells worth $0.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
3 / 0
$1.4M bought, $0 sold

Where the trades landed

Last year at the 3 companies this insider has traded most, with each buy and sell on the bar it happened.

CCLFX: Cliffwater Corporate Lending Fund

CCLFXOct 9, 2026 · close 10.18

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

CPEFX: Cascade Private Capital Fund

CPEFXOct 9, 2026 · close 22.38

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

CELFX: Cliffwater Enhanced Lending Fund

CELFXOct 9, 2026 · close 10.73

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
47Moderate
Cliffwater Corporate Lending Fund
$300k
28,463 shares
-+8% from low-0% from high
41Moderate
Cascade Private Capital Fund
$500k
24,486 shares
-+25% from low-1% from high
42Moderate
Cliffwater Enhanced Lending Fund
$600k
54,645 shares
-+11% from low0% from high

Transactions

Every row this insider has filed, 3 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Apr 1, 2026CCLFX
Cliffwater Corporate Lending Fund
POpen-market purchase
Class I Shares
+28,463$10.54$300k28,463Apr 2, 2026
Mar 25, 2026CPEFX
Cascade Private Capital Fund
POpen-market purchase
Class I Shares
+24,486$20.42$500k24,486Mar 26, 2026
Mar 18, 2026CELFX
Cliffwater Enhanced Lending Fund
POpen-market purchase
Class I Shares
+54,645$10.98$600k54,645Mar 20, 2026

Questions about Matthew Eugene Worley

Answered from the filings on this page, as of the latest one.

Is Matthew Eugene Worley buying or selling?

In the last 12 months Matthew Eugene Worley reported 3 open-market buys worth $1.4M and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $300k of CCLFX on Apr 1, 2026. Grants, option exercises and tax withholding are not counted.

How did Matthew Eugene Worley's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Matthew Eugene Worley has 0.

Where does Matthew Eugene Worley file Form 4?

Matthew Eugene Worley has filed Form 4 at CCLFX (Cliffwater Corporate Lending Fund); CELFX (Cliffwater Enhanced Lending Fund); CPEFX (Cascade Private Capital Fund). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.